Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:Urinary Bladder Neoplasm
go back to main search page
Accession:DOID:9009116 term browser browse the term
Definition:Tumors of the urinary bladder
Synonyms:exact_synonym: Bladder Neoplasm;   Bladder Neoplasms;   Bladder Tumor;   Bladder Tumors;   Urinary Bladder Neoplasms
For additional species annotation, visit the Alliance of Genome Resources.



show annotations for term's descendants           Sort by:
 
Urinary Bladder Neoplasm term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Fgfr3 fibroblast growth factor receptor 3 ISO ClinVar Annotator: match by term: Urinary Bladder Neoplasms ClinVar PMID:1908846 PMID:7773297 PMID:8589699 PMID:8858131 PMID:9677066 More... NCBI chr 5:33,721,724...33,737,068
Ensembl chr 5:33,721,674...33,737,068
JBrowse link
G Hras Harvey rat sarcoma virus oncogene ISO ClinVar Annotator: match by term: Urinary Bladder Neoplasms ClinVar PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 More... NCBI chr 7:141,189,934...141,194,019
Ensembl chr 7:141,189,105...141,194,005
JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog ISO ClinVar Annotator: match by term: Urinary Bladder Neoplasms ClinVar PMID:6695174 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16618717 More... NCBI chr 6:145,216,699...145,250,420
Ensembl chr 6:145,216,699...145,250,239
JBrowse link
G Lrrc56 leucine rich repeat containing 56 ISO ClinVar Annotator: match by term: Urinary Bladder Neoplasms ClinVar PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 More... NCBI chr 7:141,194,111...141,210,055
Ensembl chr 7:141,194,157...141,210,055
JBrowse link
G Rb1 RB transcriptional corepressor 1 ISO ClinVar Annotator: match by term: Urinary Bladder Neoplasms ClinVar PMID:1352883 PMID:7881418 PMID:9632788 PMID:9671401 PMID:10486322 More... NCBI chr14:73,192,858...73,325,951
Ensembl chr14:73,183,673...73,325,822
JBrowse link
bladder carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Fgfr3 fibroblast growth factor receptor 3 ISO ClinVar Annotator: match by term: Bladder carcinoma ClinVar PMID:7773297 PMID:8589699 PMID:8845844 PMID:9438390 PMID:9843049 More... NCBI chr 5:33,721,724...33,737,068
Ensembl chr 5:33,721,674...33,737,068
JBrowse link
G Hras Harvey rat sarcoma virus oncogene ISO ClinVar Annotator: match by term: Bladder carcinoma ClinVar PMID:16443854 PMID:18039947 PMID:19382114 PMID:21850009 PMID:22499344 More... NCBI chr 7:141,189,934...141,194,019
Ensembl chr 7:141,189,105...141,194,005
JBrowse link
G Lrrc56 leucine rich repeat containing 56 ISO ClinVar Annotator: match by term: Bladder carcinoma ClinVar PMID:16443854 PMID:18039947 PMID:19382114 PMID:21850009 PMID:22499344 More... NCBI chr 7:141,194,111...141,210,055
Ensembl chr 7:141,194,157...141,210,055
JBrowse link
G Pmf1 polyamine-modulated factor 1 disease_progression ISO RGD PMID:22682992 RGD:30296649 NCBI chr 3:88,394,138...88,410,445
Ensembl chr 3:88,394,143...88,410,331
JBrowse link
bladder squamous cell carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Pten phosphatase and tensin homolog disease_progression ISO associated with schistosomiasis;protein:decreased expression:urothelium (human) RGD PMID:26916953 RGD:127285612 NCBI chr19:32,757,577...32,826,160
Ensembl chr19:32,757,497...32,826,160
JBrowse link
bladder urothelial carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Actl7a actin-like 7a ISO RGD PMID:29058301 RGD:13831338 NCBI chr 4:56,743,422...56,744,925
Ensembl chr 4:56,743,413...56,744,925
JBrowse link
G Fgfr3 fibroblast growth factor receptor 3 severity ISO protein:increased expression:urothelial cells (human) RGD PMID:28507621 RGD:38500205 NCBI chr 5:33,721,724...33,737,068
Ensembl chr 5:33,721,674...33,737,068
JBrowse link
G Kdm6a lysine (K)-specific demethylase 6A susceptibility ISO associated with upper tract urothelial carcinoma; DNA:mutations:multiple: (human) RGD PMID:30352907 RGD:150429735 NCBI chr  X:18,160,862...18,279,936
Ensembl chr  X:18,162,575...18,279,936
JBrowse link
urinary bladder cancer term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase ISO CTD Direct Evidence: marker/mechanism CTD PMID:29644616 NCBI chr 5:137,288,247...137,294,466
Ensembl chr 5:137,287,519...137,294,466
JBrowse link
G Akt1 thymoma viral proto-oncogene 1 disease_progression ISO protein:increased expression:urinary bladder RGD PMID:18190825 RGD:2291891 NCBI chr12:112,653,821...112,674,884
Ensembl chr12:112,653,821...112,674,884
JBrowse link
G Alox12 arachidonate 12-lipoxygenase ISO protein:increased expression:urinary bladder RGD PMID:14532840 RGD:2315608 NCBI chr11:70,241,457...70,255,380
Ensembl chr11:70,241,457...70,255,353
JBrowse link
G Amacr alpha-methylacyl-CoA racemase severity ISO RGD PMID:18648853 RGD:2315629 NCBI chr15:10,981,756...10,996,624
Ensembl chr15:10,981,756...10,996,626
JBrowse link
G Amfr autocrine motility factor receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9241080 NCBI chr 8:93,971,588...94,012,640
Ensembl chr 8:93,971,588...94,012,842
JBrowse link
G Ang angiogenin, ribonuclease, RNase A family, 5 ISO protein:increased expression:plasma
protein:increased expression:urine
RGD PMID:15912517 PMID:15329320 RGD:2325700, RGD:2325704 NCBI chr14:51,091,077...51,102,009
Ensembl chr14:51,091,150...51,102,009
JBrowse link
G Ankfy1 ankyrin repeat and FYVE domain containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr11:72,690,002...72,772,146
Ensembl chr11:72,690,006...72,772,146
JBrowse link
G Anpep alanyl (membrane) aminopeptidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 7:79,821,803...79,848,210
Ensembl chr 7:79,821,803...79,861,059
JBrowse link
G Apex1 apurinic/apyrimidinic endonuclease 1 susceptibility ISO RGD PMID:19041121 RGD:2315660 NCBI chr14:50,924,949...50,927,188
Ensembl chr14:50,924,968...50,927,139
JBrowse link
G Aqp3 aquaporin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22306368 NCBI chr 4:41,092,724...41,098,183
Ensembl chr 4:41,092,722...41,098,183
JBrowse link
G Areg amphiregulin disease_progression IEP
ISO
mRNA:increased expression:urinary bladder RGD PMID:11133810 PMID:11507076 RGD:2292662, RGD:2292661 NCBI chr 5:91,139,599...91,148,432
Ensembl chr 5:91,139,599...91,148,432
JBrowse link
G Arid1a AT rich interactive domain 1A (SWI-like) ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr 4:133,679,008...133,756,769
Ensembl chr 4:133,679,008...133,756,769
JBrowse link
G As3mt arsenite methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:22747749 PMID:29669044 PMID:29859237 PMID:32539094 NCBI chr19:46,707,157...46,741,099
Ensembl chr19:46,707,458...46,741,099
JBrowse link
G Asap1 ArfGAP with SH3 domain, ankyrin repeat and PH domain1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr15:64,086,840...64,382,941
Ensembl chr15:64,086,857...64,382,919
JBrowse link
G Asxl2 ASXL transcriptional regulator 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr12:3,426,857...3,510,811
Ensembl chr12:3,426,857...3,506,852
JBrowse link
G Atm ataxia telangiectasia mutated ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr 9:53,437,122...53,536,828
Ensembl chr 9:53,439,149...53,536,740
JBrowse link
G Atp5d ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr10:80,138,698...80,145,828
Ensembl chr10:80,138,632...80,145,818
JBrowse link
G Atp5g2 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9) ISO DNA:hypermethylation:promoter RGD PMID:26929985 RGD:14696811 NCBI chr15:102,662,868...102,671,047
Ensembl chr15:102,662,864...102,672,352
JBrowse link
G Aurka aurora kinase A disease_progression ISO mRNA, protein:increased expression:urinary bladder RGD PMID:18485461 RGD:2293871 NCBI chr 2:172,356,190...172,370,886
Ensembl chr 2:172,356,190...172,370,535
JBrowse link
G Axin1 axin 1 susceptibility ISO DNA:SNPs:5'utr: (rs12921862, rs1805105, rs370681) (human) RGD PMID:31143301 RGD:150527861 NCBI chr17:26,131,217...26,195,811
Ensembl chr17:26,138,688...26,195,811
JBrowse link
G Bap1 Brca1 associated protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231345 NCBI chr14:31,251,352...31,259,930
Ensembl chr14:31,251,450...31,259,944
JBrowse link
G Bax BCL2-associated X protein ISO RGD PMID:18452128 RGD:2296023 NCBI chr 7:45,461,695...45,466,903
Ensembl chr 7:45,461,697...45,466,898
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 severity ISO DNA:hypermethylation:promoter RGD PMID:18094410 PMID:18342927 RGD:2293014, RGD:2292910 NCBI chr 1:106,538,176...106,714,290
Ensembl chr 1:106,538,178...106,714,274
JBrowse link
G Bcl2l1 BCL2-like 1 disease_progression ISO RGD PMID:18342927 RGD:2292910 NCBI chr 2:152,758,732...152,833,803
Ensembl chr 2:152,780,668...152,831,728
JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12926068 NCBI chr 9:7,847,468...7,873,205
Ensembl chr 9:7,848,699...7,873,186
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 disease_progression IMP
ISO
protein:increased expression:urinary bladder RGD PMID:18089718 PMID:17905101 RGD:2293094, RGD:2293096 NCBI chr11:117,849,237...117,855,743
Ensembl chr11:117,849,251...117,855,743
JBrowse link
G Bptf bromodomain PHD finger transcription factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr11:107,033,081...107,132,147
Ensembl chr11:107,033,081...107,132,127
JBrowse link
G Brca1 breast cancer 1, early onset ISO DNA:hypermethylation:promoter RGD PMID:18094410 RGD:2293014 NCBI chr11:101,488,761...101,551,955
Ensembl chr11:101,488,764...101,551,955
JBrowse link
G Calhm1 calcium homeostasis modulator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr19:47,141,035...47,144,174
Ensembl chr19:47,140,909...47,144,254
JBrowse link
G Car9 carbonic anhydrase 9 disease_progression ISO RGD PMID:14520462 RGD:2293197 NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729
JBrowse link
G Casp3 caspase 3 disease_progression ISO RGD PMID:17267327 RGD:2298949 NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
JBrowse link
G Casp9 caspase 9 disease_progression
susceptibility
ISO DNA:SNP:exon:p.Q221R (rs1052576) (human)
DNA:polymorphism, deletion: :1263A>G, 293del (human)
RGD PMID:19252927 PMID:19412632 RGD:2315930, RGD:2315929 NCBI chr 4:141,793,612...141,815,978
Ensembl chr 4:141,793,612...141,815,976
JBrowse link
G Cav1 caveolin 1, caveolae protein severity ISO protein:increased expression:urinary bladder RGD PMID:12866378 RGD:2289110 NCBI chr 6:17,306,335...17,341,328
Ensembl chr 6:17,306,335...17,341,452
JBrowse link
G Cbx7 chromobox 7 severity ISO mRNA:decreased expression:urinary bladder (human) RGD PMID:18984978 RGD:9587361 NCBI chr15:79,915,804...79,971,143
Ensembl chr15:79,915,807...79,971,119
JBrowse link
G Ccnd1 cyclin D1 ISO protein:increased expression:bladder RGD PMID:12372886 RGD:13602096 NCBI chr 7:144,929,931...144,939,831
Ensembl chr 7:144,929,931...144,939,925
JBrowse link
G Ccnd3 cyclin D3 disease_progression ISO RGD PMID:16482499 RGD:2316012 NCBI chr17:47,505,051...47,599,689
Ensembl chr17:47,505,051...47,599,691
JBrowse link
G Ccne1 cyclin E1 disease_progression
severity
ISO protein:decreased expression:urinary bladder
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:20972438 PMID:27514407 PMID:18047954 PMID:16739882 RGD:2296035, RGD:2289267 NCBI chr 7:38,097,984...38,107,490
Ensembl chr 7:38,097,984...38,107,534
JBrowse link
G Cd40lg CD40 ligand treatment IDA RGD PMID:16361570 RGD:7248437 NCBI chr  X:57,212,143...57,224,042
Ensembl chr  X:57,212,143...57,224,042
JBrowse link
G Cd44 CD44 antigen ISO RGD PMID:16321281 RGD:2289357 NCBI chr 2:102,811,141...102,901,669
Ensembl chr 2:102,811,141...102,901,665
JBrowse link
G Cd82 CD82 antigen disease_progression ISO protein:decreased expression:urinary bladder RGD PMID:14706010 PMID:17290345 RGD:2289401, RGD:2289391 NCBI chr 2:93,419,102...93,462,950
Ensembl chr 2:93,419,111...93,463,140
JBrowse link
G Cd9 CD9 antigen disease_progression ISO RGD PMID:14534881 RGD:2326207 NCBI chr 6:125,460,266...125,494,760
Ensembl chr 6:125,460,266...125,494,791
JBrowse link
G Cdc25a cell division cycle 25A ISO RGD PMID:17145867 RGD:2715645 NCBI chr 9:109,875,518...109,893,895
Ensembl chr 9:109,875,579...109,893,895
JBrowse link
G Cdc25b cell division cycle 25B disease_progression ISO RGD PMID:19383904 RGD:2739695 NCBI chr 2:131,186,436...131,198,511
Ensembl chr 2:131,186,949...131,198,497
JBrowse link
G Cdh1 cadherin 1 disease_progression ISO protein:decreased expression:urinary bladder
CTD Direct Evidence: marker/mechanism
Protein:increased expression:cytoplasm
CTD
RGD
PMID:17520682 PMID:26901067 PMID:17760743 PMID:17167984 RGD:2289491, RGD:1599549 NCBI chr 8:106,603,350...106,670,247
Ensembl chr 8:106,603,351...106,670,246
JBrowse link
G Cdh13 cadherin 13 ISO DNA:hypermethylation:promoter RGD PMID:18094410 RGD:2293014 NCBI chr 8:118,140,017...119,324,929
Ensembl chr 8:118,283,733...119,324,921
JBrowse link
G Cdk1 cyclin-dependent kinase 1 ISO RGD PMID:17145867 RGD:2715645 NCBI chr10:69,335,146...69,352,912
Ensembl chr10:69,335,146...69,352,938
JBrowse link
G Cdk4 cyclin-dependent kinase 4 disease_progression ISO protein:increased expression:urinary bladder
DNA:amplification
RGD PMID:16896691 PMID:11971182 RGD:2289144, RGD:2299056 NCBI chr10:127,063,535...127,067,288
Ensembl chr10:127,063,534...127,067,920
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A (P21) ISO CTD Direct Evidence: marker/mechanism CTD PMID:18640142 NCBI chr17:29,090,979...29,100,722
Ensembl chr17:29,090,976...29,100,727
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B susceptibility
disease_progression
IAGP
ISO
RGD PMID:18027869 PMID:18334837 RGD:2293595, RGD:2293592 NCBI chr 6:134,920,401...134,925,525
Ensembl chr 6:134,920,401...134,925,513
JBrowse link
G Cdkn2a cyclin dependent kinase inhibitor 2A ISO protein:increased expression:urinary bladder
CTD Direct Evidence: marker/mechanism|therapeutic
DNA:deletion
DNA:hypermethylation:promoter
CTD
RGD
PMID:12973940 PMID:15987713 PMID:18234280 PMID:15897688 PMID:17119258 RGD:2296048, RGD:2289687, RGD:2296052 NCBI chr 4:89,274,473...89,294,619
Ensembl chr 4:89,274,471...89,294,653
JBrowse link
G Cdkn2b cyclin dependent kinase inhibitor 2B disease_progression ISO DNA:deletion:urinary bladder RGD PMID:15590562 PMID:16624482 RGD:2289696, RGD:7248757 NCBI chr 4:89,306,289...89,311,032
Ensembl chr 4:89,306,299...89,311,039
JBrowse link
G Chd6 chromodomain helicase DNA binding protein 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr 2:160,946,978...161,109,086
Ensembl chr 2:160,946,978...161,109,075
JBrowse link
G Chek2 checkpoint kinase 2 susceptibility
treatment
ISO DNA:mutations: :multiple RGD PMID:17918154 PMID:21396995 RGD:2289704, RGD:10401655 NCBI chr 5:110,839,800...110,874,140
Ensembl chr 5:110,839,979...110,874,145
JBrowse link
G Clptm1l CLPTM1-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:19151717 NCBI chr13:73,604,002...73,620,639
Ensembl chr13:73,604,006...73,620,605
JBrowse link
G Comt catechol-O-methyltransferase ISO protein:increased expression:urinary bladder, urine RGD PMID:15596044 RGD:2289726 NCBI chr16:18,406,882...18,426,716
Ensembl chr16:18,406,886...18,426,852
JBrowse link
G Crebbp CREB binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr16:4,081,334...4,213,957
Ensembl chr16:4,081,328...4,213,997
JBrowse link
G Csf3 colony stimulating factor 3 (granulocyte) ISO CTD Direct Evidence: therapeutic CTD PMID:7525883 PMID:17515069 NCBI chr11:98,700,183...98,703,631
Ensembl chr11:98,701,263...98,703,629
JBrowse link
G Ctnna1 catenin (cadherin associated protein), alpha 1 disease_progression ISO RGD PMID:17760743 RGD:2289491 NCBI chr18:35,118,902...35,254,776
Ensembl chr18:35,118,859...35,254,779
JBrowse link
G Ctnnb1 catenin (cadherin associated protein), beta 1 disease_progression ISO
IEA
OMIM:109800 MouseDO
RGD
PMID:17175927 RGD:2289829 NCBI chr 9:120,933,400...120,960,507
Ensembl chr 9:120,929,216...120,960,507
JBrowse link
G Ctsb cathepsin B ISO protein:increased activity:transitional cell carcinoma (human) RGD PMID:15183956 RGD:2315615 NCBI chr14:63,122,462...63,145,923
Ensembl chr14:63,122,462...63,145,923
JBrowse link
G Cxcl15 chemokine (C-X-C motif) ligand 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22015448 NCBI chr 5:90,794,534...90,803,067
Ensembl chr 5:90,794,534...90,803,067
JBrowse link
G Cxcr2 chemokine (C-X-C motif) receptor 2 ISO DNA:SNP RGD PMID:19252927 RGD:2315930 NCBI chr 1:74,153,994...74,161,246
Ensembl chr 1:74,153,989...74,161,246
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 IMP RGD PMID:17406000 RGD:7257712 NCBI chr 9:54,165,937...54,268,164
Ensembl chr 9:54,165,937...54,268,110
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 no_association ISO DNA:polymorphisms: :3801T>C (human)
DNA:polymorphism: :2455A>G (human)
RGD PMID:21990318 PMID:18200441 PMID:18979064 RGD:7257730, RGD:7257736, RGD:7257733 NCBI chr 9:57,687,928...57,703,824
Ensembl chr 9:57,687,928...57,703,824
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 ISO RGD PMID:21990318 RGD:7257730 NCBI chr17:79,706,940...79,715,061
Ensembl chr17:79,701,537...79,715,061
JBrowse link
G Cyp2c55 cytochrome P450, family 2, subfamily c, polypeptide 55 ISO RGD PMID:16985032 RGD:6903918 NCBI chr19:39,006,940...39,042,690
Ensembl chr19:39,007,019...39,042,693
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 ISO RGD PMID:16985032 RGD:6903918 NCBI chr19:39,061,006...39,093,948
Ensembl chr19:39,061,015...39,093,944
JBrowse link
G Cyp2c66 cytochrome P450, family 2, subfamily c, polypeptide 66 ISO RGD PMID:16985032 RGD:6903918 NCBI chr19:39,113,898...39,186,756
Ensembl chr19:39,113,898...39,187,072
JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18713828 NCBI chr 4:115,624,698...115,647,721
Ensembl chr 4:115,624,725...115,647,723
JBrowse link
G Dapk1 death associated protein kinase 1 ISO DNA:hypermethylation RGD PMID:12124340 RGD:734875 NCBI chr13:60,601,723...60,763,191
Ensembl chr13:60,601,947...60,763,191
JBrowse link
G Dnmt1 DNA methyltransferase (cytosine-5) 1 ISO protein:increased expression (in humans) RGD PMID:14634451 RGD:2301220 NCBI chr 9:20,907,206...20,959,888
Ensembl chr 9:20,907,209...20,959,888
JBrowse link
G Dusp1 dual specificity phosphatase 1 disease_progression ISO RGD PMID:17690186 RGD:2298694 NCBI chr17:26,505,591...26,508,472
Ensembl chr17:26,505,590...26,562,128
JBrowse link
G E2f1 E2F transcription factor 1 disease_progression ISO mRNA:increased expression:bladder RGD PMID:20421545 RGD:13602004 NCBI chr 2:154,559,400...154,569,892
Ensembl chr 2:154,559,407...154,569,892
JBrowse link
G Eef1e1 eukaryotic translation elongation factor 1 epsilon 1 disease_progression ISO protein:decreased expression:urothelium: RGD PMID:24917520 RGD:10401219 NCBI chr13:38,645,691...38,659,028
Ensembl chr13:38,644,207...38,659,058
JBrowse link
G Egfr epidermal growth factor receptor disease_progression ISO protein:increased expression:urinary bladder
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:11723127 PMID:23523951 PMID:18006009 PMID:16685269 RGD:2289943, RGD:2298502 NCBI chr11:16,752,203...16,913,907
Ensembl chr11:16,752,203...16,918,158
JBrowse link
G Eno2 enolase 2, gamma neuronal ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:22613180 PMID:17951193 RGD:2293738 NCBI chr 6:124,760,053...124,769,673
Ensembl chr 6:124,760,053...124,769,673
JBrowse link
G Eomes eomesodermin ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 9:118,478,186...118,486,132
Ensembl chr 9:118,478,212...118,486,132
JBrowse link
G Ep300 E1A binding protein p300 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr15:81,586,209...81,652,077
Ensembl chr15:81,585,351...81,652,077
JBrowse link
G Ephx1 epoxide hydrolase 1, microsomal disease_progression ISO DNA:SNPs RGD PMID:19252927 RGD:2315930 NCBI chr 1:180,989,556...181,017,569
Ensembl chr 1:180,976,210...181,020,904
JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 disease_progression ISO RGD PMID:16685269 PMID:16771730 RGD:2298502, RGD:2289934 NCBI chr11:98,412,484...98,437,716
Ensembl chr11:98,412,470...98,437,716
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 disease_progression ISO RGD PMID:16685269 RGD:2298502 NCBI chr10:128,567,523...128,589,635
Ensembl chr10:128,567,523...128,589,652
JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 disease_progression ISO protein:decreased expression:urinary bladder RGD PMID:18006009 PMID:16685269 RGD:2289943, RGD:2298502 NCBI chr 1:68,031,884...69,108,576
Ensembl chr 1:68,032,186...69,108,059
JBrowse link
G Ercc2 excision repair cross-complementing rodent repair deficiency, complementation group 2 disease_progression ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:24121791 PMID:27111033 PMID:25316812 RGD:11252208 NCBI chr 7:19,382,017...19,395,694
Ensembl chr 7:19,382,010...19,395,694
JBrowse link
G Ercc4 excision repair cross-complementing rodent repair deficiency, complementation group 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20062074 NCBI chr16:13,109,366...13,152,009
Ensembl chr16:13,109,684...13,150,617
JBrowse link
G Espl1 extra spindle pole bodies 1, separase ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121792 NCBI chr15:102,296,254...102,324,357
Ensembl chr15:102,296,266...102,324,357
JBrowse link
G Esr1 estrogen receptor 1 (alpha) ISO CTD Direct Evidence: marker/mechanism CTD PMID:16712894 NCBI chr10:4,611,989...5,005,633
Ensembl chr10:4,611,593...5,005,614
JBrowse link
G Esr2 estrogen receptor 2 (beta) severity ISO protein:increased expression:urinary bladder urothelium (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16700038 PMID:23612777 RGD:7364758 NCBI chr12:76,120,419...76,177,259
Ensembl chr12:76,120,419...76,177,259
JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit ISO mRNA:increased expression:urinary bladder RGD PMID:21539681 RGD:126781700 NCBI chr 6:47,530,274...47,595,270
Ensembl chr 6:47,530,139...47,595,341
JBrowse link
G F2 coagulation factor II severity ISO protein:increased expression:urine RGD PMID:22236518 RGD:6893573 NCBI chr 2:91,612,397...91,636,457
Ensembl chr 2:91,625,320...91,636,414
JBrowse link
G Fanca Fanconi anemia, complementation group A ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:24121791 PMID:19237606 RGD:11344902 NCBI chr 8:123,266,294...123,318,651
Ensembl chr 8:123,268,300...123,318,576
JBrowse link
G Fas Fas (TNF receptor superfamily member 6) susceptibility ISO DNA:polymorphisms:promoter:-1377G>A,-670A>G
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:9070496 PMID:16538171 RGD:2290063 NCBI chr19:34,290,647...34,327,775
Ensembl chr19:34,290,666...34,327,772
JBrowse link
G Fasl Fas ligand (TNF superfamily, member 6) susceptibility ISO DNA:polymorphisms:promoter:-844T>C RGD PMID:16538171 RGD:2290063 NCBI chr 1:161,780,691...161,788,495
Ensembl chr 1:161,780,689...161,788,495
JBrowse link
G Fbxw8 F-box and WD-40 domain protein 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 5:118,064,981...118,155,458
Ensembl chr 5:118,064,965...118,155,464
JBrowse link
G Fermt2 fermitin family member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21624607 NCBI chr14:45,458,792...45,530,310
Ensembl chr14:45,458,795...45,530,118
JBrowse link
G Fgf1 fibroblast growth factor 1 ISO RGD PMID:11908679 RGD:2290291 NCBI chr18:38,838,672...38,929,470
Ensembl chr18:38,838,673...38,929,472
JBrowse link
G Fgf2 fibroblast growth factor 2 ISO RGD PMID:11908679 RGD:2290291 NCBI chr 3:37,348,477...37,410,106
Ensembl chr 3:37,348,346...37,410,108
JBrowse link
G Fgfr2 fibroblast growth factor receptor 2 ISO DNA:hypermethylation, loss of heterozygosity, deletions:exon (human)
associated with Acrocephalosyndactylia (MeSH:D000168)
RGD PMID:10602477 PMID:16969861 RGD:2301193, RGD:2289664 NCBI chr 7:130,162,451...130,266,808
Ensembl chr 7:130,162,451...133,123,350
JBrowse link
G Fgfr3 fibroblast growth factor receptor 3 severity
disease_progression
ISO DNA:mutations
ClinVar Annotator: match by term: Urinary bladder cancer
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Malignant tumor of urinary bladder
protein:increased expression:urinary bladder
ClinVar
CTD
OMIM
RGD
PMID:1908846 PMID:7773297 PMID:8589699 PMID:8858131 PMID:9677066 More... RGD:2301223, RGD:2301224, RGD:2301225, RGD:2301222, RGD:2289864 NCBI chr 5:33,721,724...33,737,068
Ensembl chr 5:33,721,674...33,737,068
JBrowse link
G Fhit fragile histidine triad gene ISO
IEP
associated with Schistosomiasis;DNA:hypermethylation:urinary bladder
protein:decreased expression:urinary bladder
RGD PMID:15154012 PMID:11751381 PMID:15591090 RGD:2301233, RGD:2289897, RGD:2301232 NCBI chr14:9,550,092...11,162,061
Ensembl chr14:9,550,092...11,162,035
JBrowse link
G Fn1 fibronectin 1 ISO protein:increased expression:urine RGD PMID:20012564 RGD:7205680 NCBI chr 1:71,585,473...71,653,280
Ensembl chr 1:71,585,520...71,653,200
JBrowse link
G Ggh gamma-glutamyl hydrolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19815704 NCBI chr 4:20,041,997...20,066,111
Ensembl chr 4:20,042,052...20,066,750
JBrowse link
G Gli1 GLI-Kruppel family member GLI1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20179202 NCBI chr10:127,329,882...127,341,579
Ensembl chr10:127,329,882...127,341,974
JBrowse link
G Gm21188 predicted gene, 21188 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr13:120,034,604...120,052,204
Ensembl chr13:120,026,439...120,027,011
Ensembl chr13:120,026,439...120,027,011
JBrowse link
G Gpx1 glutathione peroxidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15247771 NCBI chr 9:108,339,080...108,340,342
Ensembl chr 9:108,338,903...108,340,343
JBrowse link
G Gstm1 glutathione S-transferase, mu 1 susceptibility ISO DNA:deletion: : (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:18505952 PMID:20972438 PMID:18544563 RGD:6906879 NCBI chr 3:108,012,250...108,017,973
Ensembl chr 3:108,012,255...108,017,973
JBrowse link
G Gsto2 glutathione S-transferase omega 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22306368 NCBI chr19:47,865,438...47,886,308
Ensembl chr19:47,865,534...47,886,324
JBrowse link
G Gstp1 glutathione S-transferase, pi 1 ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:urinary bladder
CTD
RGD
PMID:7729958 PMID:12500666 PMID:22306368 PMID:18544563 PMID:21213404 More... RGD:6906879, RGD:10401939, RGD:6906883 NCBI chr19:4,035,411...4,037,912
Ensembl chr19:4,035,407...4,037,985
JBrowse link
G Gstt1 glutathione S-transferase, theta 1 susceptibility ISO DNA:deletion: : (human) RGD PMID:18544563 RGD:6906879 NCBI chr10:75,783,813...75,798,584
Ensembl chr10:75,783,813...75,798,584
JBrowse link
G Gstz1 glutathione transferase zeta 1 (maleylacetoacetate isomerase) ISO CTD Direct Evidence: marker/mechanism CTD PMID:22306368 NCBI chr12:87,147,161...87,164,723
Ensembl chr12:87,147,165...87,164,723
JBrowse link
G H19 H19, imprinted maternally expressed transcript ISO
IEP
DNA:hypomethylation
DNA:SNP
mRNA:increased expression:urinary bladder
RGD PMID:18950807 PMID:11726548 PMID:18262338 PMID:9886562 RGD:2306168, RGD:2306180, RGD:2306171, RGD:2306184 NCBI chr 7:142,575,530...142,578,146
Ensembl chr 7:142,575,529...142,578,143
JBrowse link
G Hdac4 histone deacetylase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21507255 NCBI chr 1:91,928,779...92,195,702
Ensembl chr 1:91,928,779...92,195,699
JBrowse link
G Hk1 hexokinase 1 treatment ISO RGD PMID:23893687 RGD:11353960 NCBI chr10:62,268,855...62,379,920
Ensembl chr10:62,268,855...62,379,908
JBrowse link
G Hmbs hydroxymethylbilane synthase ISO urinary bladder transitional cell carcinoma; mRNA:decreased expression:tumor:in matched malignant and non-malignant sample pairs (p = 0.008) (human) RGD PMID:16600798 RGD:2301681 NCBI chr 9:44,336,348...44,344,228
Ensembl chr 9:44,336,339...44,344,228
JBrowse link
G Hmgb3 high mobility group box 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30639441 NCBI chr  X:71,555,917...71,560,673
Ensembl chr  X:71,555,918...71,560,676
JBrowse link
G Hmgn5 high-mobility group nucleosome binding domain 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22109888 NCBI chr  X:109,004,537...109,013,380
Ensembl chr  X:109,004,534...109,013,404
JBrowse link
G Hoxa9 homeobox A9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26332997 NCBI chr 6:52,223,097...52,227,370
Ensembl chr 6:52,223,100...52,231,089
JBrowse link
G Hras Harvey rat sarcoma virus oncogene disease_progression ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder
ClinVar Annotator: match by term: Urinary bladder cancer
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
OMIM
RGD
PMID:2228319 PMID:2278634 PMID:2999610 PMID:3537694 PMID:6092966 More... RGD:2314833, RGD:11060144 NCBI chr 7:141,189,934...141,194,019
Ensembl chr 7:141,189,105...141,194,005
JBrowse link
G Hspa1a heat shock protein 1A treatment ISO RGD PMID:19914824 RGD:7242743 NCBI chr17:34,969,359...34,972,156
Ensembl chr17:34,969,190...34,972,156
JBrowse link
G Icam1 intercellular adhesion molecule 1 ISO protein:increased expression:serum: RGD PMID:7686390 RGD:11520780 NCBI chr 9:21,015,940...21,028,814
Ensembl chr 9:21,015,985...21,028,817
JBrowse link
G Ifna interferon alpha EXP CTD Direct Evidence: therapeutic CTD PMID:1674182 PMID:2297754
G Ifna2 interferon alpha 2 ISO CTD Direct Evidence: therapeutic CTD PMID:17172406 NCBI chr 4:88,683,207...88,683,779
Ensembl chr 4:88,682,881...88,683,912
JBrowse link
G Ifnb1 interferon beta 1, fibroblast ISO CTD Direct Evidence: therapeutic CTD PMID:2297754 NCBI chr 4:88,522,025...88,522,794
Ensembl chr 4:88,522,025...88,522,774
JBrowse link
G Ifng interferon gamma treatment ISO
IDA
protein:decreased expression:serum RGD PMID:22906662 PMID:11219496 RGD:6893349, RGD:8157619 NCBI chr10:118,441,046...118,445,894
Ensembl chr10:118,441,046...118,445,892
JBrowse link
G Igf1 insulin-like growth factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19415693 NCBI chr10:87,858,265...87,937,047
Ensembl chr10:87,858,265...87,937,042
JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:21347663 PMID:12544349 RGD:2290028 NCBI chr11:7,206,086...7,215,498
Ensembl chr11:7,206,086...7,213,923
JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 1:72,858,065...72,874,865
Ensembl chr 1:72,857,932...72,874,884
JBrowse link
G Igsf21 immunoglobulin superfamily, member 21 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 4:140,026,852...140,246,983
Ensembl chr 4:140,026,846...140,246,784
JBrowse link
G Il1b interleukin 1 beta disease_progression ISO mRNA:increased expression:urinary bladder tumor (human) RGD PMID:21308147 RGD:7175327 NCBI chr 2:129,364,569...129,371,164
Ensembl chr 2:129,364,570...129,371,139
JBrowse link
G Il1rn interleukin 1 receptor antagonist susceptibility ISO DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human)
DNA:repeats:intron:IVS2+914_1000dup multiple (human)
RGD PMID:19489682 PMID:16698387 RGD:6907081, RGD:6907367 NCBI chr 2:24,336,860...24,351,491
Ensembl chr 2:24,336,853...24,351,494
JBrowse link
G Il2 interleukin 2 treatment ISO CTD Direct Evidence: therapeutic CTD
RGD
PMID:1949363 PMID:3495671 PMID:3262172 RGD:8663471 NCBI chr 3:37,120,713...37,125,954
Ensembl chr 3:37,120,523...37,125,959
JBrowse link
G Inpp4b inositol polyphosphate-4-phosphatase, type II ISO CTD Direct Evidence: marker/mechanism CTD PMID:29415082 NCBI chr 8:81,342,266...82,134,312
Ensembl chr 8:81,342,556...82,127,914
JBrowse link
G Isl1 ISL1 transcription factor, LIM/homeodomain ISO CTD Direct Evidence: marker/mechanism CTD PMID:26332997 NCBI chr13:116,298,270...116,309,688
Ensembl chr13:116,298,281...116,309,689
JBrowse link
G Jup junction plakoglobin disease_progression
severity
ISO
IEP
protein:altered localization:tumor:loss of membrane expression associated with higher grade (p<0.05), higher stage (p<0.05), and poor survival (p<0.05)
DNA, protein:mutations, increased expression:urinary bladder
RGD PMID:9783980 PMID:17363521 PMID:11585741 RGD:2291880, RGD:2289818, RGD:2301748 NCBI chr11:100,368,856...100,397,839
Ensembl chr11:100,368,958...100,397,763
JBrowse link
G Kdm4a lysine (K)-specific demethylase 4A ISO mRNA:increased expression:urinary bladder (human) RGD PMID:23603248 RGD:9587435 NCBI chr 4:118,136,957...118,180,090
Ensembl chr 4:118,136,957...118,180,043
JBrowse link
G Kdm4b lysine (K)-specific demethylase 4B ISO mRNA, protein:increased expression:urinary bladder (human) RGD PMID:21930796 RGD:9587740 NCBI chr17:56,325,970...56,403,774
Ensembl chr17:56,326,062...56,402,870
JBrowse link
G Kdm5b lysine (K)-specific demethylase 5B ISO mRNA:increased expression:urinary bladder (human) RGD PMID:20226085 RGD:9587778 NCBI chr 1:134,560,178...134,632,878
Ensembl chr 1:134,560,171...134,635,285
JBrowse link
G Kdm6a lysine (K)-specific demethylase 6A ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr  X:18,160,862...18,279,936
Ensembl chr  X:18,162,575...18,279,936
JBrowse link
G Kdr kinase insert domain protein receptor severity ISO RGD PMID:12940780 PMID:12215294 RGD:2291949, RGD:2301758 NCBI chr 5:75,932,827...75,979,072
Ensembl chr 5:75,932,827...75,978,458
JBrowse link
G Kiss1 KiSS-1 metastasis-suppressor ISO RGD PMID:12547718 RGD:2292136 NCBI chr 1:133,321,887...133,329,722
Ensembl chr 1:133,309,827...133,329,722
Ensembl chr 1:133,309,827...133,329,722
JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase ISO urinary bladder small cell carcinoma RGD PMID:15502806 RGD:2292430 NCBI chr 5:75,574,987...75,656,722
Ensembl chr 5:75,574,916...75,656,722
JBrowse link
G Klf5 Kruppel-like factor 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27514407 NCBI chr14:99,298,691...99,313,412
Ensembl chr14:99,298,691...99,315,036
JBrowse link
G Kmt2a lysine (K)-specific methyltransferase 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr 9:44,803,355...44,881,352
Ensembl chr 9:44,803,355...44,881,296
JBrowse link
G Kmt2c lysine (K)-specific methyltransferase 2C ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr 5:25,271,795...25,498,855
Ensembl chr 5:25,271,798...25,498,783
JBrowse link
G Kmt2d lysine (K)-specific methyltransferase 2D ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr15:98,831,669...98,874,077
Ensembl chr15:98,831,669...98,871,204
JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog ISO transitional cell bladder carcinoma, OMIM:109800
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Bladder cancer
ClinVar Annotator: match by term: Bladder cancer, transitional cell, somatic
CTD
ClinVar
OMIM
RGD
PMID:1553789 PMID:6695174 PMID:12460918 PMID:15696205 PMID:16361624 More... RGD:1600467 NCBI chr 6:145,216,699...145,250,420
Ensembl chr 6:145,216,699...145,250,239
JBrowse link
G Krt16 keratin 16 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20186695 NCBI chr11:100,246,091...100,248,902
Ensembl chr11:100,246,091...100,248,902
JBrowse link
G Krt5 keratin 5 ISO RGD PMID:7507402 RGD:1600196 NCBI chr15:101,707,069...101,712,905
Ensembl chr15:101,707,070...101,712,898
JBrowse link
G Lama2 laminin, alpha 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr10:26,981,285...27,617,191
Ensembl chr10:26,980,036...27,619,758
JBrowse link
G Lig1 ligase I, DNA, ATP-dependent ISO CTD Direct Evidence: marker/mechanism CTD PMID:8631603 NCBI chr 7:13,277,175...13,311,426
Ensembl chr 7:13,277,283...13,311,433
JBrowse link
G Loxl1 lysyl oxidase-like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17456585 NCBI chr 9:58,287,723...58,313,212
Ensembl chr 9:58,287,738...58,313,186
JBrowse link
G Loxl4 lysyl oxidase-like 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17456585 NCBI chr19:42,592,279...42,612,806
Ensembl chr19:42,593,982...42,612,813
JBrowse link
G Lrrc56 leucine rich repeat containing 56 ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder
ClinVar Annotator: match by term: Urinary bladder cancer
ClinVar Annotator: match by term: Bladder cancer
ClinVar PMID:2999610 PMID:3537694 PMID:6092966 PMID:6330729 PMID:7177195 More... NCBI chr 7:141,194,111...141,210,055
Ensembl chr 7:141,194,157...141,210,055
JBrowse link
G Magea9 MAGE family member A9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17290406 NCBI chr  X:64,173,548...64,178,779
Ensembl chr  X:64,173,548...64,178,778
JBrowse link
G Map2k4 mitogen-activated protein kinase kinase 4 ISO RGD PMID:15665277 RGD:2306057 NCBI chr11:65,688,244...65,788,359
Ensembl chr11:65,688,243...65,788,297
JBrowse link
G Mapk15 mitogen-activated protein kinase 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr15:75,993,732...75,999,153
Ensembl chr15:75,993,769...75,999,154
JBrowse link
G Mdm2 transformed mouse 3T3 cell double minute 2 severity ISO mRNA:increased expression:bladder RGD PMID:27798881 RGD:13602098 NCBI chr10:117,688,875...117,710,758
Ensembl chr10:117,688,875...117,710,758
JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase susceptibility ISO DNA:polymorphisms:cds:p.L53L, p.L84F (human) RGD PMID:15885889 RGD:2317672 NCBI chr 7:136,894,463...137,128,193
Ensembl chr 7:136,894,614...137,130,266
JBrowse link
G Mir100 microRNA 100 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30026881 NCBI chr 9:41,531,425...41,531,504
Ensembl chr 9:41,531,425...41,531,504
JBrowse link
G Mir145a microRNA 145a ISO CTD Direct Evidence: marker/mechanism CTD PMID:30026881 NCBI chr18:61,647,825...61,647,894
Ensembl chr18:61,647,825...61,647,894
JBrowse link
G Mir152 microRNA 152 severity ISO miRNA:decreased expression:urinary bladder RGD PMID:30015946 RGD:19165141 NCBI chr11:96,850,393...96,850,465
Ensembl chr11:96,850,393...96,850,465
JBrowse link
G Mir29c microRNA 29c ISO CTD Direct Evidence: marker/mechanism CTD PMID:30026881 NCBI chr 1:195,037,547...195,037,634
Ensembl chr 1:195,037,547...195,037,634
JBrowse link
G Mir34b microRNA 34b ISO CTD Direct Evidence: marker/mechanism CTD PMID:30026881 NCBI chr 9:51,103,562...51,103,645
Ensembl chr 9:51,103,562...51,103,645
JBrowse link
G Mir532 microRNA 532 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30639441 NCBI chr  X:7,248,402...7,248,497
Ensembl chr  X:7,248,402...7,248,497
JBrowse link
G Mir99a microRNA 99a ISO CTD Direct Evidence: marker/mechanism CTD PMID:30026881 NCBI chr16:77,598,936...77,599,000
Ensembl chr16:77,598,936...77,599,000
JBrowse link
G Mki67 antigen identified by monoclonal antibody Ki 67 ISO protein:increased expression:urinary bladder RGD PMID:20367636 RGD:2317708 NCBI chr 7:135,689,784...135,716,450
Ensembl chr 7:135,689,784...135,716,361
JBrowse link
G Mlh1 mutL homolog 1 disease_progression ISO RGD PMID:15296997 RGD:2293518 NCBI chr 9:111,228,228...111,271,786
Ensembl chr 9:111,228,228...111,271,791
JBrowse link
G Mmp13 matrix metallopeptidase 13 ISO urinary bladder transitional-cell carcinomas RGD PMID:11054671 RGD:2293609 NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
JBrowse link
G Mmp1a matrix metallopeptidase 1a (interstitial collagenase) severity ISO DNA:insertion:promoter:g.-1607insG (human)
protein:increased expression:urine (human)
RGD PMID:17986285 PMID:11705862 RGD:7207077, RGD:7207140 NCBI chr 9:7,464,141...7,476,869
Ensembl chr 9:7,464,141...7,476,869
JBrowse link
G Mmp1b matrix metallopeptidase 1b (interstitial collagenase) severity ISO protein:increased expression:urine (human)
DNA:insertion:promoter:g.-1607insG (human)
RGD PMID:11705862 PMID:17986285 RGD:7207077 RGD:7207140 NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
JBrowse link
G Mmp2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:30548095 PMID:17466450 RGD:2290395 NCBI chr 8:92,827,290...92,853,421
Ensembl chr 8:92,827,291...92,853,420
JBrowse link
G Mmp9 matrix metallopeptidase 9 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:30548095 PMID:17466450 RGD:2290395 NCBI chr 2:164,940,326...164,955,850
Ensembl chr 2:164,940,780...164,955,850
JBrowse link
G Mpo myeloperoxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:14729580 NCBI chr11:87,793,784...87,804,412
Ensembl chr11:87,793,581...87,804,413
JBrowse link
G Mre11a MRE11A homolog A, double strand break repair nuclease susceptibility ISO DNA:snp:3' utr:c.2501A>G rs2155209 (human)
ClinVar Annotator: match by term: Malignant tumor of urinary bladder
ClinVar Annotator: match by term: Urinary Bladder Neoplasms
ClinVar
RGD
PMID:28492532 PMID:18638378 RGD:2317733 NCBI chr 9:14,784,654...14,837,125
Ensembl chr 9:14,784,654...14,837,123
JBrowse link
G Msh2 mutS homolog 2 disease_progression ISO DNA:mutation
DNA:mutations: :multiple
associated with Lynch syndrome
protein:decreased expression:urinary bladder
RGD PMID:18389386 PMID:26385421 PMID:22883484 PMID:18254781 RGD:2293502, RGD:126790580, RGD:126790557, RGD:2293503 NCBI chr17:87,672,532...87,723,713
Ensembl chr17:87,672,330...87,723,713
JBrowse link
G Msh6 mutS homolog 6 disease_progression ISO protein:decreased expression:urinary bladder RGD PMID:18254781 RGD:2293503 NCBI chr17:87,975,050...87,990,892
Ensembl chr17:87,975,062...87,990,892
JBrowse link
G mt-Atp8 ATP synthase 8, mitochondrial ISO DNA:deletion: :(human) RGD PMID:15254717 RGD:2302294 NCBI chr MT:7,766...7,969
Ensembl chr MT:7,766...7,969
JBrowse link
G mt-Cytb cytochrome b, mitochondrial ISO DNA:deletion:cds RGD PMID:18245469 RGD:2298953 NCBI chr MT:14,145...15,288
Ensembl chr MT:14,145...15,288
JBrowse link
G mt-Nd2 NADH dehydrogenase 2, mitochondrial ISO DNA:deletion: :(human) RGD PMID:15254717 RGD:2302294 NCBI chr MT:3,914...4,951
Ensembl chr MT:3,914...4,951
JBrowse link
G Mt2 metallothionein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:7729958 PMID:16565513 NCBI chr 8:94,172,618...94,173,567
Ensembl chr 8:94,172,664...94,173,568
JBrowse link
G Mt3 metallothionein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16854967 NCBI chr 8:94,152,607...94,154,148
Ensembl chr 8:94,152,607...94,154,146
JBrowse link
G Mthfr methylenetetrahydrofolate reductase susceptibility
no_association
ISO DNA:transition:cds:g.677C>T (human)
CTD Direct Evidence: marker/mechanism
protein:missense mutation:cds:p.A222V (human)
DNA:transversion:cds:g.1298A>C (human)
DNA:transition, transversion, haplotype:cds:g.677C>T, g.1298A>C (human)
CTD
RGD
PMID:22747749 PMID:22126575 PMID:17311259 PMID:19837268 PMID:20146887 RGD:6893457, RGD:6893597, RGD:6893521, RGD:6893516 NCBI chr 4:148,039,077...148,059,562
Ensembl chr 4:148,039,077...148,059,551
JBrowse link
G Mtor mechanistic target of rapamycin kinase treatment IMP RGD PMID:19261747 RGD:10040979 NCBI chr 4:148,448,582...148,557,685
Ensembl chr 4:148,448,611...148,557,683
JBrowse link
G Mtr 5-methyltetrahydrofolate-homocysteine methyltransferase susceptibility ISO DNA:polymorphism: :2756A>G(human) RGD PMID:19837268 RGD:6893521 NCBI chr13:12,181,331...12,258,199
Ensembl chr13:12,182,712...12,258,113
JBrowse link
G Muc1 mucin 1, transmembrane ISO protein:increased expression:serum: RGD PMID:10468735 RGD:7245967 NCBI chr 3:89,229,056...89,233,381
Ensembl chr 3:89,229,057...89,233,381
JBrowse link
G Muc5b mucin 5, subtype B, tracheobronchial ISO DNA:repeats RGD PMID:19191526 RGD:7349339 NCBI chr 7:141,839,059...141,873,089
Ensembl chr 7:141,839,070...141,873,084
JBrowse link
G Myc myelocytomatosis oncogene susceptibility
disease_progression
ISO
IDA
DNA:snp, haplotype:enhancer:g.-30772G>T rs9642880 (human)
CTD Direct Evidence: marker/mechanism
protein:decreased expression:urinary bladder urothelium (human)
CTD
RGD
PMID:2228319 PMID:23284801 PMID:20939013 PMID:22028816 RGD:7207401, RGD:7207427, RGD:7207418 NCBI chr15:61,985,341...61,990,361
Ensembl chr15:61,985,391...61,990,374
JBrowse link
G Nat1 N-acetyl transferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16003747 NCBI chr 8:67,490,968...67,492,531
Ensembl chr 8:67,480,921...67,492,104
JBrowse link
G Nat2 N-acetyltransferase 2 (arylamine N-acetyltransferase) susceptibility ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:10022756 PMID:15717312 PMID:18505952 PMID:20972438 PMID:24221535 More... RGD:8552670 NCBI chr 8:67,494,875...67,502,644
Ensembl chr 8:67,494,858...67,502,584
JBrowse link
G Ncan neurocan ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 8:70,093,085...70,120,863
Ensembl chr 8:70,093,085...70,120,873
JBrowse link
G Ncor1 nuclear receptor co-repressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr11:62,315,663...62,457,414
Ensembl chr11:62,316,426...62,458,541
JBrowse link
G Ncstn nicastrin IEA OMIM:109800 MouseDO NCBI chr 1:172,066,013...172,082,789
Ensembl chr 1:172,066,013...172,082,795
JBrowse link
G Nectin2 nectin cell adhesion molecule 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29321541 NCBI chr 7:19,716,644...19,749,573
Ensembl chr 7:19,716,644...19,750,483
JBrowse link
G Nedd4 neural precursor cell expressed, developmentally down-regulated 4 ISO RGD PMID:17726579 RGD:2302550 NCBI chr 9:72,662,331...72,749,851
Ensembl chr 9:72,662,346...72,749,852
JBrowse link
G Nme1 NME/NM23 nucleoside diphosphate kinase 1 ISO mRNA:increased expression:urinary bladder RGD PMID:7614395 RGD:2299071 NCBI chr11:93,958,925...93,968,272
Ensembl chr11:93,956,979...93,968,521
JBrowse link
G Nme2 NME/NM23 nucleoside diphosphate kinase 2 ISO mRNA:increased expression:urinary bladder RGD PMID:7614395 RGD:2299071 NCBI chr11:93,949,814...93,956,256
Ensembl chr11:93,949,814...93,956,259
JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell ISO protein:increased expression:urinary bladder RGD PMID:10475345 RGD:2292089 NCBI chr 5:24,364,816...24,384,474
Ensembl chr 5:24,364,810...24,384,474
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 treatment ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:8631603 PMID:21213404 RGD:10401939 NCBI chr 8:107,388,225...107,403,205
Ensembl chr 8:107,388,225...107,403,206
JBrowse link
G Nrsn1 neurensin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr13:25,252,039...25,269,996
Ensembl chr13:25,252,040...25,270,502
JBrowse link
G Olfr283 olfactory receptor 283 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr15:98,378,096...98,379,197
Ensembl chr15:98,377,699...98,380,946
JBrowse link
G Pabpc1 poly(A) binding protein, cytoplasmic 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25783786 NCBI chr15:36,595,658...36,609,581
Ensembl chr15:36,595,661...36,609,668
JBrowse link
G Phb prohibitin ISO mRNA:increased expression:urinary bladder RGD PMID:8062216 RGD:2292407 NCBI chr11:95,666,957...95,680,773
Ensembl chr11:95,666,957...95,680,773
JBrowse link
G Plau plasminogen activator, urokinase treatment ISO protein:increased expression:urinary bladder (human)
DNA:snp:3' utr:g.4065C>T (human)
RGD PMID:19010488 PMID:18336603 PMID:16825821 RGD:4144867, RGD:7241213, RGD:7241144 NCBI chr14:20,836,662...20,843,388
Ensembl chr14:20,836,660...20,843,385
JBrowse link
G Plk1 polo like kinase 1 severity ISO RGD PMID:16837776 PMID:15761500 RGD:2299938, RGD:2299940 NCBI chr 7:122,159,435...122,169,884
Ensembl chr 7:122,159,439...122,169,873
JBrowse link
G Pmf1 polyamine-modulated factor 1 disease_progression ISO RGD PMID:19088041 RGD:30296651 NCBI chr 3:88,394,138...88,410,445
Ensembl chr 3:88,394,143...88,410,331
JBrowse link
G Pms2 PMS1 homolog2, mismatch repair system component susceptibility ISO DNA:SNP: :rs6463524 (human) RGD PMID:19692168 RGD:2315025 NCBI chr 5:143,909,901...143,972,745
Ensembl chr 5:143,909,964...143,933,968
JBrowse link
G Polb polymerase (DNA directed), beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:8631603 NCBI chr 8:22,628,119...22,653,464
Ensembl chr 8:22,628,126...22,653,435
JBrowse link
G Por cytochrome p450 oxidoreductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:8631603 NCBI chr 5:135,670,040...135,735,326
Ensembl chr 5:135,670,033...135,735,326
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma ISO protein:decreased expression:urinary bladder RGD PMID:18712722 RGD:2301870 NCBI chr 6:115,360,879...115,490,404
Ensembl chr 6:115,360,951...115,490,399
JBrowse link
G Ppp3cc protein phosphatase 3, catalytic subunit, gamma isoform ISO CTD Direct Evidence: marker/mechanism CTD PMID:29275364 NCBI chr14:70,217,864...70,289,536
Ensembl chr14:70,217,865...70,289,471
JBrowse link
G Prdm2 PR domain containing 2, with ZNF domain ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 4:143,107,391...143,212,769
Ensembl chr 4:143,107,391...143,212,995
JBrowse link
G Prkca protein kinase C, alpha severity
disease_progression
ISO protein:increased expression:urinary bladder
protein:altered localization:urinary bladder
RGD PMID:16008942 PMID:15922420 RGD:2292455, RGD:2298669 NCBI chr11:107,933,387...108,343,888
Ensembl chr11:107,933,387...108,343,928
JBrowse link
G Psca prostate stem cell antigen ISO CTD Direct Evidence: marker/mechanism CTD PMID:19648920 PMID:20083643 NCBI chr15:74,714,839...74,717,065
Ensembl chr15:74,714,839...74,717,069
JBrowse link
G Psmb2 proteasome (prosome, macropain) subunit, beta type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 4:126,677,637...126,709,715
Ensembl chr 4:126,677,630...126,709,714
JBrowse link
G Pten phosphatase and tensin homolog disease_progression ISO
IEA
DNA:mutations: :multiple
OMIM:109800
protein:decreased expression:urinary bladder
MouseDO
RGD
PMID:9671402 PMID:18190825 RGD:2292515, RGD:2291891 NCBI chr19:32,757,577...32,826,160
Ensembl chr19:32,757,497...32,826,160
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 disease_progression
susceptibility
IMP
ISO
CTD Direct Evidence: marker/mechanism
DNA:SNP:3' utr:837T>C (human)
CTD
RGD
PMID:10582676 PMID:10873095 PMID:12442003 PMID:12664575 PMID:16098373 More... RGD:2300200, RGD:5508302, RGD:2300127 NCBI chr 1:150,100,031...150,108,234
Ensembl chr 1:150,100,031...150,108,227
JBrowse link
G Ralbp1 ralA binding protein 1 ISO mRNA, protein:increased expression:urinary bladder RGD PMID:17606711 RGD:2324917 NCBI chr17:65,848,415...65,885,755
Ensembl chr17:65,848,418...65,885,798
JBrowse link
G Ralgps1 Ral GEF with PH domain and SH3 binding motif 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 2:33,133,419...33,371,499
Ensembl chr 2:33,133,417...33,371,486
JBrowse link
G Rassf1 Ras association (RalGDS/AF-6) domain family member 1 ISO DNA:hypermethylation
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:15987713 PMID:18702824 PMID:12222680 RGD:2299860, RGD:2291977 NCBI chr 9:107,551,434...107,562,267
Ensembl chr 9:107,551,555...107,562,267
JBrowse link
G Rb1 RB transcriptional corepressor 1 disease_progression ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder
ClinVar Annotator: match by term: Urinary bladder cancer
ClinVar
OMIM
RGD
PMID:1352883 PMID:2181449 PMID:7881418 PMID:9632788 PMID:9671401 More... RGD:2299888 NCBI chr14:73,192,858...73,325,951
Ensembl chr14:73,183,673...73,325,822
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) disease_progression ISO
IEP
RGD PMID:18188593 PMID:18089718 RGD:2298753, RGD:2293094 NCBI chr19:5,637,442...5,648,134
Ensembl chr19:5,637,483...5,648,130
JBrowse link
G Retn resistin ISO protein:increased expression:urine RGD PMID:18373357 RGD:7207154 NCBI chr 8:3,655,770...3,659,818
Ensembl chr 8:3,655,770...3,660,110
JBrowse link
G Rhoa ras homolog family member A disease_progression ISO protein:increased expression:urinary bladder
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:19896475 PMID:12855641 RGD:2298872 NCBI chr 9:108,306,160...108,337,943
Ensembl chr 9:108,306,129...108,337,934
JBrowse link
G Rrm2 ribonucleotide reductase M2 IEP mRNA:increased expression:bladder (mouse) RGD PMID:21139803 RGD:5133688 NCBI chr12:24,708,254...24,714,146
Ensembl chr12:24,708,241...24,714,146
JBrowse link
G Runx3 runt related transcription factor 3 ISO DNA:hypermethylation:promoter RGD PMID:16230397 RGD:2302553 NCBI chr 4:135,120,645...135,177,990
Ensembl chr 4:135,120,652...135,177,990
JBrowse link
G S100a8 S100 calcium binding protein A8 (calgranulin A) IEP mRNA:increased expression:urinary bladder RGD PMID:17970044 RGD:2316906 NCBI chr 3:90,669,071...90,670,034
Ensembl chr 3:90,668,978...90,670,035
JBrowse link
G S100a9 S100 calcium binding protein A9 (calgranulin B) IEP mRNA:increased expression:urinary bladder RGD PMID:17970044 RGD:2316906 NCBI chr 3:90,692,630...90,695,721
Ensembl chr 3:90,692,632...90,695,721
JBrowse link
G S100b S100 protein, beta polypeptide, neural IEP mRNA:decreased expression:urinary bladder urothelium RGD PMID:17970044 RGD:2316906 NCBI chr10:76,253,836...76,261,319
Ensembl chr10:76,253,853...76,261,159
JBrowse link
G Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 ISO RGD PMID:19010488 RGD:4144867 NCBI chr 5:137,061,504...137,072,272
Ensembl chr 5:137,061,504...137,072,268
JBrowse link
G Sfn stratifin disease_progression ISO protein:increased expression:urothelium (human) RGD PMID:17645415 RGD:2299928 NCBI chr 4:133,600,556...133,602,168
Ensembl chr 4:133,600,556...133,602,168
JBrowse link
G Slc11a1 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 disease_progression ISO DNA:repeat, polymorphism:promoter, cds:p.D543N (human) RGD PMID:16516037 RGD:5684951 NCBI chr 1:74,375,014...74,386,057
Ensembl chr 1:74,375,195...74,386,062
JBrowse link
G Slc12a7 solute carrier family 12, member 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr13:73,733,052...73,816,754
Ensembl chr13:73,733,094...73,816,754
JBrowse link
G Slc19a1 solute carrier family 19 (folate transporter), member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21760912 NCBI chr10:77,032,269...77,050,432
Ensembl chr10:77,032,241...77,061,002
JBrowse link
G Smad2 SMAD family member 2 IEP RGD PMID:15548366 RGD:2299964 NCBI chr18:76,241,090...76,311,748
Ensembl chr18:76,241,580...76,310,963
JBrowse link
G Smad4 SMAD family member 4 ISO protein:decreased expression:urinary bladder RGD PMID:11783019 RGD:2299972 NCBI chr18:73,634,790...73,703,791
Ensembl chr18:73,639,009...73,703,780
JBrowse link
G Smc1a structural maintenance of chromosomes 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr  X:152,016,428...152,061,973
Ensembl chr  X:152,016,428...152,062,694
JBrowse link
G Smc1b structural maintenance of chromosomes 1B ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr15:85,064,689...85,131,957
Ensembl chr15:85,064,689...85,131,964
JBrowse link
G Socs1 suppressor of cytokine signaling 1 disease_progression ISO DNA:hypermethylation:promoter RGD PMID:16242928 PMID:17522834 RGD:2298906, RGD:2298903 NCBI chr16:10,783,808...10,785,536
Ensembl chr16:10,782,240...10,785,536
JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:14729580 PMID:18930813 PMID:17974967 RGD:7175539 NCBI chr17:13,007,839...13,018,119
Ensembl chr17:13,006,846...13,040,063
JBrowse link
G Sox2 SRY (sex determining region Y)-box 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29396848 NCBI chr 3:34,649,995...34,652,461
Ensembl chr 3:34,650,405...34,652,461
JBrowse link
G Sox4 SRY (sex determining region Y)-box 4 ISO RGD PMID:16585165 RGD:1581304 NCBI chr13:28,948,919...28,953,699
Ensembl chr13:28,948,919...28,953,713
JBrowse link
G Sparc secreted acidic cysteine rich glycoprotein disease_progression ISO RGD PMID:11696817 PMID:17149610 RGD:2300024, RGD:2300021 NCBI chr11:55,394,159...55,420,080
Ensembl chr11:55,394,500...55,423,183
JBrowse link
G Spink1 serine peptidase inhibitor, Kazal type 1 disease_progression ISO mRNA, protein:decreased expression:urinary bladder RGD PMID:16327984 RGD:2300384 NCBI chr18:43,728,069...43,737,237
Ensembl chr18:43,728,082...43,737,557
JBrowse link
G Spp1 secreted phosphoprotein 1 ISO RGD PMID:21483670 RGD:6903265 NCBI chr 5:104,435,111...104,441,053
Ensembl chr 5:104,435,118...104,441,050
JBrowse link
G Src Rous sarcoma oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:11723127 PMID:17093206 NCBI chr 2:157,423,906...157,471,838
Ensembl chr 2:157,418,444...157,471,862
JBrowse link
G Srsf9 serine and arginine-rich splicing factor 9 ISO mRNA:increased expression:urinary bladder epithelium (human) RGD PMID:22178073 RGD:11040443 NCBI chr 5:115,327,163...115,333,843
Ensembl chr 5:115,327,177...115,333,080
JBrowse link
G Stag2 stromal antigen 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121789 PMID:24121791 PMID:24121792 NCBI chr  X:42,149,297...42,277,186
Ensembl chr  X:42,149,317...42,277,185
JBrowse link
G Sult1a1 sulfotransferase family 1A, phenol-preferring, member 1 ISO RGD PMID:14643027 RGD:1581442 NCBI chr 7:126,672,865...126,690,443
Ensembl chr 7:126,672,865...126,676,432
JBrowse link
G Tacc3 transforming, acidic coiled-coil containing protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121792 NCBI chr 5:33,658,128...33,672,203
Ensembl chr 5:33,658,128...33,678,995
JBrowse link
G Terc telomerase RNA component disease_progression ISO RNA:increased expression:urinary bladder
RNA:increased expression:urine
RGD PMID:16104909 PMID:17644139 RGD:2291967, RGD:2291986 NCBI chr 3:96,414,437...96,414,833
Ensembl chr 3:96,414,437...96,414,859
Ensembl chr 3:96,414,437...96,414,859
JBrowse link
G Tert telomerase reverse transcriptase ISO protein:increased expression:urine
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:19151717 PMID:17644139 RGD:2291986 NCBI chr13:73,626,911...73,649,843
Ensembl chr13:73,626,911...73,649,843
JBrowse link
G Tff1 trefoil factor 1 ISO protein:increased expression:urinary bladder RGD PMID:18283638 RGD:2291996 NCBI chr17:31,161,395...31,165,060
Ensembl chr17:31,161,395...31,165,277
JBrowse link
G Tfrc transferrin receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:16904380 NCBI chr16:32,608,896...32,632,794
Ensembl chr16:32,608,920...32,632,794
JBrowse link
G Tgfbr1 transforming growth factor, beta receptor I ISO RGD PMID:9363992 RGD:2302036 NCBI chr 4:47,353,222...47,414,926
Ensembl chr 4:47,353,222...47,414,931
JBrowse link
G Thbs1 thrombospondin 1 severity ISO protein:decreased expression:bladder RGD PMID:20299037 RGD:13602099 NCBI chr 2:118,111,876...118,127,133
Ensembl chr 2:118,111,876...118,127,133
JBrowse link
G Timp2 tissue inhibitor of metalloproteinase 2 disease_progression ISO protein:decreased expression:serum
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:30548095 PMID:17374529 PMID:17466450 RGD:2298521, RGD:2290395 NCBI chr11:118,301,061...118,355,411
Ensembl chr11:118,301,069...118,355,740
JBrowse link
G Timp3 tissue inhibitor of metalloproteinase 3 ISO DNA:hypermethylation:promoter RGD PMID:18082200 RGD:2290411 NCBI chr10:86,300,412...86,349,505
Ensembl chr10:86,300,372...86,349,506
JBrowse link
G Tlr2 toll-like receptor 2 ISO DNA:deletion:promoter:−196_−174del (human) RGD PMID:23142523 RGD:7207893 NCBI chr 3:83,836,272...83,841,824
Ensembl chr 3:83,836,272...83,841,767
JBrowse link
G Tlr4 toll-like receptor 4 treatment IMP RGD PMID:19788935 RGD:7240556 NCBI chr 4:66,827,551...66,846,581
Ensembl chr 4:66,827,584...66,930,284
JBrowse link
G Tmeff2 transmembrane protein with EGF-like and two follistatin-like domains 2 ISO DNA:hypermethylation:promoter RGD PMID:16234815 RGD:2290489 NCBI chr 1:50,900,683...51,187,270
Ensembl chr 1:50,900,647...51,187,270
JBrowse link
G Tnf tumor necrosis factor ISO CTD Direct Evidence: therapeutic CTD PMID:1674182 NCBI chr17:35,199,367...35,202,007
Ensembl chr17:35,199,381...35,202,007
JBrowse link
G Tnfrsf10b tumor necrosis factor receptor superfamily, member 10b ISO DNA:missense mutation:cds:p.E228A (c.683A>C) (human) RGD PMID:16217763 RGD:11038717 NCBI chr14:69,767,472...69,784,411
Ensembl chr14:69,767,472...69,784,411
JBrowse link
G Top2a topoisomerase (DNA) II alpha disease_progression ISO RGD PMID:19913893 RGD:2315121 NCBI chr11:98,992,947...99,024,199
Ensembl chr11:98,992,943...99,024,189
JBrowse link
G Trp53 transformation related protein 53 disease_progression ISO
EXP
protein:increased expression:urinary bladder
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:9610789 PMID:11376694 PMID:12376482 PMID:12706858 PMID:15906354 More... RGD:2290536 NCBI chr11:69,580,348...69,591,873
Ensembl chr11:69,580,359...69,591,873
JBrowse link
G Trp63 transformation related protein 63 disease_progression ISO RGD PMID:19690775 RGD:2315430 NCBI chr16:25,683,763...25,892,088
Ensembl chr16:25,683,763...25,892,102
JBrowse link
G Trp73 transformation related protein 73 disease_progression ISO mRNA:increased expression:urinary bladder RGD PMID:10383132 RGD:2291836 NCBI chr 4:154,056,249...154,139,875
Ensembl chr 4:154,056,253...154,140,208
Ensembl chr 4:154,056,253...154,140,208
JBrowse link
G Trpv1 transient receptor potential cation channel, subfamily V, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19502594 NCBI chr11:73,234,149...73,261,322
Ensembl chr11:73,234,292...73,261,242
JBrowse link
G Try4 trypsin 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15987713 NCBI chr 6:41,302,272...41,305,533
Ensembl chr 6:41,302,269...41,305,532
JBrowse link
G Tsc1 TSC complex subunit 1 ISO ClinVar Annotator: match by term: Bladder cancer
ClinVar Annotator: match by term: Urinary bladder cancer
ClinVar Annotator: match by term: Malignant tumor of urinary bladder
ClinVar PMID:9242607 PMID:9328481 PMID:9803264 PMID:9863590 PMID:9924605 More... NCBI chr 2:28,640,993...28,691,172
Ensembl chr 2:28,641,228...28,691,167
JBrowse link
G Tymp thymidine phosphorylase disease_progression ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:11103787 PMID:15841086 PMID:16937303 RGD:2293716 NCBI chr15:89,371,631...89,377,036
Ensembl chr15:89,371,931...89,377,039
JBrowse link
G Tyms thymidylate synthase ISO RGD PMID:18463958 RGD:2317413 NCBI chr 5:30,038,546...30,073,645
Ensembl chr 5:30,058,202...30,073,617
JBrowse link
G Ube2i ubiquitin-conjugating enzyme E2I ISO radiation-induced dysplasia and carcinoma in situ; protein:increased expression:bladder urothelium:increased in Chernobyl victims vs controls from uncontaminated areas of the Ukraine (p<0.001) (human) RGD PMID:16407042 RGD:2301343 NCBI chr17:25,260,510...25,275,799
Ensembl chr17:25,261,916...25,274,622
JBrowse link
G Ugt2b34 UDP glucuronosyltransferase 2 family, polypeptide B34 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15615884 NCBI chr 5:86,889,770...86,906,937
Ensembl chr 5:86,889,767...86,906,937
JBrowse link
G Usp7 ubiquitin specific peptidase 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr16:8,688,722...8,757,067
Ensembl chr16:8,689,595...8,792,308
JBrowse link
G Vegfa vascular endothelial growth factor A ISO mRNA:increased expression:bladder RGD PMID:22895562 RGD:13605607 NCBI chr17:46,016,993...46,032,377
Ensembl chr17:46,016,993...46,032,369
JBrowse link
G Vegfc vascular endothelial growth factor C disease_progression ISO RGD PMID:17094484 RGD:2315482 NCBI chr 8:54,077,532...54,186,454
Ensembl chr 8:54,077,606...54,187,096
JBrowse link
G Vegfd vascular endothelial growth factor D disease_progression ISO RGD PMID:17970053 RGD:2315479 NCBI chr  X:164,373,522...164,402,650
Ensembl chr  X:164,373,378...164,402,650
JBrowse link
G Vhl von Hippel-Lindau tumor suppressor ISO mRNA:decreased expression:urinary bladder RGD PMID:19399409 RGD:2325183 NCBI chr 6:113,623,994...113,631,634
Ensembl chr 6:113,623,959...113,631,633
JBrowse link
G Vwa3a von Willebrand factor A domain containing 3A ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 7:120,737,331...120,805,546
Ensembl chr 7:120,739,318...120,805,742
JBrowse link
G Wif1 Wnt inhibitory factor 1 disease_progression ISO protein:decreased expression:urinary bladder
DNA:hypermethylation:promoter
RGD PMID:14517837 PMID:18325051 RGD:727214, RGD:2291868 NCBI chr10:121,034,004...121,100,642
Ensembl chr10:121,033,960...121,100,650
JBrowse link
G Wnt7b wingless-type MMTV integration site family, member 7B ISO superficial, NOT invasive RGD PMID:9461004 RGD:2299932 NCBI chr15:85,535,437...85,581,821
Ensembl chr15:85,535,437...85,582,473
JBrowse link
G Xdh xanthine dehydrogenase ISO protein:decreased activity:urinary bladder RGD PMID:20087949 RGD:7247647 NCBI chr17:73,883,895...73,950,397
Ensembl chr17:73,883,895...73,950,196
JBrowse link
G Xrcc1 X-ray repair complementing defective repair in Chinese hamster cells 1 susceptibility
no_association
ISO DNA:polymorphism: :p.R399Q
DNA:SNP: p.R399Q (human)
DNA:polymorphisms: :multiple
RGD PMID:18765423 PMID:18272472 PMID:17425776 RGD:2302568, RGD:150530493, RGD:2302572 NCBI chr 7:24,546,699...24,573,438
Ensembl chr 7:24,546,289...24,573,440
JBrowse link
G Yjefn3 YjeF N-terminal domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 8:69,887,788...69,893,983
Ensembl chr 8:69,887,788...69,902,712
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 14615
    disease of anatomical entity 14222
      Urogenital Diseases 4102
        urinary system disease 1882
          bladder disease 406
            Urinary Bladder Neoplasm 284
              bladder benign neoplasm + 0
              urinary bladder cancer + 284
paths to the root